Therapeutic effect of exogenous hsp70 in mouse models of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Brain deterioration resulting from "protein folding" diseases, such as the Alzheimer's disease (AD), is one of the leading causes of morbidity and mortality in the aging human population. Heat shock proteins (Hsps) constitute the major cellular quality control system for proteins that mitigates the pathological burden of neurotoxic protein fibrils and aggregates. However, the therapeutic effect of Hsps has not been tested in a relevant setting. Here we report the dramatic neuroprotective effect of recombinant human Hsp70 in the bilateral olfactory bulbectomy model (OBX mice) and 5XFAD mouse models of neurodegeneration. We show that intranasally-administered Hsp70 rapidly enters the afflicted brain regions and mitigates multiple AD-like morphological and cognitive abnormalities observed in model animals. In particular, in both cases it normalizes the density of neurons in the hippocampus and cortex which correlates with the diminished accumulation of amyloid-β (Aβ) peptide and, in the case of 5XFAD mice, reduces Aβ plaque formation. Consistently, Hsp70 treatment also protects spatial memory in OBX and 5XFAD mice. These studies demonstrate that exogenous Hsp70 may be a practical therapeutic agent for treatment of neurodegenerative diseases associated with abnormal protein biogenesis and cognitive disturbances, such as AD, for which neuroprotective therapy is urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · cited 1×
“E-mail: evgeny.nudler@nyumc.org. neurons, including the quantity of neurofibrillary tangles , the decrease in synaptic density, the enhanced concentration of soluble amyloid- (A) oligomers, and the amount of neurons that die by apoptosis [1] [2] [3].”
The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1×
“It is likely that the level of soluble A and its aggregates are mostly responsible for the cytotoxicity [37].”
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 5×
“In contrast to OBX animals, they are characterized by a high level of amyloid plaques that appear early in their lifespan in different brain regions [12].”
MethodInfluentialAlzheimer’s Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2007) · Advances in Behavioral Biology · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,468
Intraneuronal Aβ42 Accumulation in Human Brain
Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991 · cited 1×
“Thus it was demonstrated that intracellular accumulation of A is an early event in neuronal dysfunction [38] and cytosolic A has been shown to be highly cytotoxic to primary neurons [39].”
The olfactory bulbectomised rat as a model of depression
Song, C., & Leonard, B. E. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.010 · Cited by 698 · cited 1×
“OBX animals exhibit functional, morphological, and biochemical characteristics similar to those described for AD patients [2, 17, 18], including severe memory loss [11, 13–16].”
Hanson, L. R., & Frey, W. H. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s5 · Cited by 697 · cited 1×
“Precise mechanisms providing such transport are not known and may involve neuron terminals, bulk flow and diffusion within perineuronal channels, perivascular spaces, or lymphatic channels directly connected to brain tissue [36].”
Reger, M. A., Watson, G. S., Green, P. S., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Cherrier, M. M., Schellenberg, G. D., Frey II, W. H., et al. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13309 · Cited by 521 · cited 1×
“Thus, intranasal administration of insulin was found effective to modulate verbal memory and plasma A in memory-impaired older adults and in other model systems [48, 49].”
Cummings, C. J. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.14.1511 · Cited by 485 · cited 1×
“Several observations demonstrate that chaperones belonging to Hsp70 family can ameliorate cellular toxicity of aberrantly folded proteins extant in AD, Parkinson’s disease, amyotrophic lateral sclerosis, and polyQ-diseases [4, 34, 35], suggesting that treatment with Hsp70 could potentially be therapeutic for these dev…”
Research works printed but not linked: 4
- [2][2] Reisberg B, Saeed MU (2004) Alzheimer's disease. In Comprehensive Textbook of Geriatric Psychiatry, 3rd edition, Sadavoy J, Jarvik LF, Grossberg GT, Meyers BS, eds. WW Norton, New York, pp. 449-509. -
- [11][11] Bobkova NV, Nesterova I, Medvinskaya N, Samokhin A, Alexandrova I (2005) Possible role of the olfactory system in Alzheimer's disease genesis. In New Trends in Alzheimer and Parkinson Disorders: ADPD 2005 , Fisher A, Hanin I, Memo M, Stocchi F, eds. Medimond, Sorento, pp. 91-95. -
- [20][20] Wilson MC, et al. (1994) Regulation of the olfactory bulb Alzheimer's precursor protein (APP) by lesioning of the olfactory bulb. Soc Neurosci 509 (8), 1249. -
- [34][34] Margulis B, Kinev A, Guzhova I (2006) Chaperones in neurodegenerative pathologies: Therapeutic prospects. In Heat Shock Proteins in Biology and Medicine , Radons J, Multhoff G, eds. Research Signpost, Kerala, pp. 305-329. -
Cited by
Items 101–138 of 138
Kuzubova, E. V., Radchenko, A. I., Pokrovsky, V. M., Patrakhanov, E. A., Novikova, A. A., Stepenko, Y. V., & Deykin, A. V. (2022) · RESEARCH RESULTS IN BIOMEDICINE · doi:10.18413/2658-6533-2022-8-4-0-6 · Cited by 4
Liu, L., Wan, W., Chen, W., Chan, Y., Shen, Q., & Li, Y. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/8591656 · Cited by 5
“Virally mediated Hsp70 overexpression rescued neurons from the toxic effects of intracellular Aβ accumulation [15], and exogenousHsp70 can reduce Aβ plaque formation in 5XFAD mice [16].”
BackgroundAPOE and Alzheimer's disease: Pathologic clues from transgenic Drosophila melanogaster
Haddadi, M., Haghi, M., Rezaei, N., Kiani, Z., Akkülah, T., & Çelik, A. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105420 · Cited by 6
Multifaceted roles of mammalian heat shock factor 1 in the central nervous system
Rozema, N. B., & Gómez‐Pastor, R. (2025) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2025.100109 · Cited by 9
“30,33,34,71,73,89 The role of HSF1 in the regulation of genes associated with these functions within the CNS, unfortunately, remains understudied, particularly with emphasis on HSF1 activity under physiological conditions that would be invaluable to better understand therapeutic effects observed in…”
Role of HSP70 in Plasticity and Memory
Porto, R. R., & Alvares, L. D. O. (2019) · Heat shock proteins · doi:10.1007/978-3-030-24285-5_5 · Cited by 3
Heat Shock Factor 1 and Its Small Molecule Modulators with Therapeutic Potential
Dutta, N., Pal, K., & Pal, M. (2020) · Heat shock proteins · doi:10.1007/7515_2020_15 · Cited by 3
Molecular Functions of Heat Shock Proteins
Evgen’ev, M. B., Garbuz, D. G., & Zatsepina, O. G. (2014) · Springer eBooks · doi:10.1007/978-94-017-9235-6_2 · Cited by 3
Self-citationIntranasal Administration of Hsp70: Molecular and Therapeutic Consequences
Evgen’ev, M. B., Garbuz, D. G., Morozov, A. V., & Bobkova, N. V. (2018) · Heat shock proteins · doi:10.1007/978-3-319-89551-2_16 · Cited by 5
Self-citationBobkova, N. V., Chuvakova, L. N., Kononova, S. V., Kovalev, V. I., Sukhikh, G. T., Zatsepina, O. G., Rezvykh, A. P., & Евгеньев, М. Б. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05135-6 · Cited by 5
“The rodents after olfactory bulbectomy (OB) recapitulate many of the key features of AD, and have been widely used in the research of AD [12, 14, 36].”
Self-citationHeat therapy increases brain HSP70 and BDNF content in male mice
Bellaflor, S., Barfoot, M. K., Boddy, J., Wallace, P. J., Baranowski, R. W., Cheung, S. S., Fajardo, V. A., & MacPherson, R. E. K. (2025) · Journal of Neurophysiology · doi:10.1152/jn.00301.2025 · Cited by 2
Girardi, C. S., Yi, L., Fitz, N. F., Gelain, D. P., Lefterov, I. M., & Koldamova, R. P. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052435 · Cited by 2
“Furthermore, extracellular HSPs are known to be neuroprotective and anti-inflammatory [81,82].”
Ji, R., Smith, M., Jackson-Lewis, V. R., Przedborski, S., & Konofagou, E. E. (2018) · IEEE International Ultrasonics Symposium · doi:10.1109/ultsym.2018.8579859 · Cited by 2
Heat Shock Proteins in Neural Signaling: Implications in Health and Disease
Mishra, P. S., & Singh, A. P. (2019) · Heat shock proteins · doi:10.1007/978-3-030-03952-3_22 · Cited by 2
Semenyuk, P. I., Evstafeva, D., Izumrudov, V. A., & Muronetz, V. I. (2022) · Polymers · doi:10.3390/polym14071478 · Cited by 2
“Thus, overproduction of Hsp70 and Hsp104 inhibited the propagation of yeast prion and huntingtin [8–10], and some therapeutic effect of Hsp70 has also been shown for Alzheimer’s disease [11].”
BackgroundSmirnova, S. V., Kurkieva, A. G., Манухов, И. В., Fomin, V. V., & Abilev, S. K. (2025) · Russian Journal of Genetics · doi:10.1134/s1022795425701145 · Cited by 1
“Secreted Hsp70 has high neuroprotective activity, increases neuronal survival under the influence of a number of stress factors, and also reduces the level of neuronal apoptosis in models of some neurodegenerative diseases [14–16].”
Vikhareva, E. A., Chicheva, M. M., Evgen’ev, M. B., Funikov, S. Y., Deykin, A. V., Бачурин, С. О., & Ustyugov, A. A. (2021) · Neurochemical Journal · doi:10.1134/s1819712421010141 · Cited by 1
Self-citationNedogreeva, O. A., Лазарева, Н. А., Stepanichev, M. Y., & Gulyaeva, N. V. (2021) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-021-01131-0 · Cited by 1
Полтавцева, Р. А., Bobkova, N. V., Zhdanova, D. Y., Svirshchevskaya, E. V., & Sukhikh, G. T. (2021) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747821050068 · Cited by 3
Self-citationRezvykh, A. P., Юринская, М. М., Винокуров, М. Г., Krasnov, G. S., Mitkevich, V. A., Makarov, A. А., Evgen’ev, M. B., & Zatsepina, O. G. (2018) · Molecular Biology · doi:10.1134/s0026898418060150 · Cited by 1
Self-citationLi, K., Liu, F., Wang, J., & Zhu, L. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.06.590
Effects of Nobiletin in Animal Models of Cognitive Impairment
Nakajima, A., Ohizumi, Y., & Yamada, K. (2017) · Wiley eBooks · doi:10.1002/9781119155195.ch21 · Cited by 1
Understanding the role of stress granules in the inner ear
Gonçalves, A. G. (2017) · UCL Discovery (University College London)
CHAPERONES AS MOLECULAR TARGET FOR ONCOLOGICAL AND NEUROLOGICAL DISEASES
Guzhova, I. V. (2018) · Pathophysiology · doi:10.1016/j.pathophys.2018.07.070
Stan, D. M. (2018) · University of Salford Institutional Repository (University of Salford)
Koch, B. M. E. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7716
“…(A2D) can bind monomeric and oligomeric Aβ-peptides and facilitate efflux across the blood brain barrier (Beeg et al., 2016; Biere et al., 1996; Bobkova et al., 2014; Hoshino et al., 2013; Iwata et al., 2013; Iwata et al., 2001; Melchor et al., 2003; Narayan et al., 2011; Yepes et al., 2003).”
BackgroundRezvykh, A. P., Yurinskaya, M. M., Винокуров, М. Г., Krasnov, G. S., Mitkevich, V. A., Makarov, A. А., Evgen’ev, M. B., & Zatsepina, O. G. (2018) · Molecular Biology · doi:10.1134/s0026893318060158
Self-citationEmerging Therapeutic Approaches for Neurodegenerative Diseases
Ugale, R. R., & Sarode, L. P. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815040913122010013
Synergistic MAPT mutations as a platform to uncover modifiers of tau pathogenesisPreprint
Bryan, M. R., Almeida, M. F., Pellegrino, K., Opland, C. K., Paulakonis, J. E., McGillion-Moore, J., Trzeciakiewicz, H., King, D. P., Tian, X., Tseng, J., et al. (2025) · eLife · doi:10.7554/elife.109145 · Cited by 1
Synergistic MAPT mutations as a platform to uncover modifiers of tau pathogenesisPreprint
Bryan, M. R., Almeida, M. F., Pellegrino, K., Opland, C. K., Paulakonis, J. E., McGillion-Moore, J., Trzeciakiewicz, H., King, D. P., Tian, X., Tseng, J., et al. (2025) · eLife · doi:10.7554/elife.109145.1
HSP-1-specific nanobodies alter chaperone function in vitro and in vivo
Urban, N. D., Gharat, K., Mattiola, Z., Scheutzow, A., Klaiss, A., Tabler, S., Huffaker, A. W., Grootveld, M., Skinner, M. E., Zheng, W., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111238
“With current clinical research exploring inhibitors and activators, HSP70s remain promising therapeutic targets for age-related diseases and conditions involving protein misfolding (16, 17).”
Kuzubova, E. V., Stepenko, Y. V., Radchenko, A. I., Rumyantseva, A. M., Rzhevskaya, M. A., Apostol, A. A., Zhunusov, N. S., Adonina, A. Y., Artyushkova, E. B., Гудырев, О. С., et al. (2026) · Pharmacy & Pharmacology · doi:10.19163/2307-9266-2026-14-1-97-108
Krauklis, S. A., Keceli, S. K., Campbell, E. M., & Abbineni, P. S. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70532 · Cited by 1
“Extracellular HSP70 is neuroprotective in mouse models of Alzheimer's disease (Kim et al. 2020; Bobkova et al. 2014), yet it can act as a DAMP activating TLR4 (Mo et al. 2022).”
Patabandi, P. P. S. K. P., Norouzitallab, P., Debnath, D., Dalvi, R. S., Sinha, A. K., Ghaffar, M. A., Sung, Y. Y., & Baruah, K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1795910
“Teleost fi sh possess functional antigen-presenting cells and major histocompatibility complex pathways, suggesting that some aspects of Hsp70-mediated antigen processing may be conserved (160 – 162).”
rAAV‑mediated Hsp70 gene delivery alleviates FUS‑associated ALS‑like pathologyPreprint
Bronovitsky, E. V., Esmagambetov, I. B., Khizeva, A., Ryabova, E. I., Orlova, E., Dovgiy, M. A., Derkaev, A. A., Blinov, A., Funikov, S., Evgen'Ev, M., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10968247/v1
Self-citationProteostasis and ageing dissidence
Babu, N. L., Whalen, K. M., & Freeman, B. (2026) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2025.0266 · Cited by 1
“Intriguingly, the localized administration of exogenous Hsp70 by intranasal administration not only extends the lifespan of mice, but also improves memory [69 ].”
Marshall, J. P. S., Harutyunyan, A., Ng, J., West, O. M., Collins, J. M., King, A. E., Morizzi, J., Wright, P., Calkin, A. C., Drew, B. G., et al. (2026) · Journal of Neuroscience Research · doi:10.1002/jnr.70161
“In an alternative model, intranasally administered recombinant human Hsp72 was found to reduce Aβ plaque formation in a mouse model of AD, which coincided with a normalization of neuron density in the hippocampus and a protection of spatial memory (Bobkova et al. 2014).”
Metadata
- Authors
- Bobkova, N. V., Garbuz, D. G., Nesterova, I., Medvinskaya, N., Samokhin, A., Alexandrova, I., Yashin, V., Karpov, V., Kukharsky, M. S., Ninkina, N. N., Smirnov, A. A., Nudler, E., & Evgen'ev, M.
- Affiliations
- Institute of Cell Biophysics, RAS, Pushchino, Moscow region, Russia
- Engelhardt Institute of Molecular Biology (RU)
- Institute of Cell Biophysics (RU)
- Engelhardt Institute of Molecular Biology, Moscow, Russia
- Institute of Physiologically Active Compounds (RU)
- Cardiff University (GB)
- Institute of Theoretical and Experimental Biophysics (RU)
- New York University (US)
- Corresponding author
- Nudler, Evgeny
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2013-11-13
- Volume
- 38
- Issue
- 2
- Pages
- 425-435
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1899777911
- Cited by
- 138
- References
- 45
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 9 · 2023: 6 · 2022: 9 · 2021: 10 · 2020: 7 · 2019: 12 · 2018: 14 · 2017: 12 · 2016: 16 · 2015: 14 · 2014: 7 · 2013: 1
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, other-oa)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- Funders
- Bethlehem Griffiths Research Foundation
- Russian Foundation for Basic Research
- Dynasty Foundation
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- HSP70, Alzheimer's disease
- MeSH terms
- Administration, Intranasal, Alzheimer Disease, Animals, Olfaction Disorders, Cerebral Cortex, Disease Models, Animal, Hippocampus, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Olfactory Bulb, Amyloid beta-Protein Precursor, HSP70 Heat-Shock Proteins, Mice, Presenilin-1, Amyloidogenic Proteins, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.